Search Results - "RAKSTANG, Jonathan K"

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Administration of a soluble recombinant complement C3 inhibitor protects against renal disease in MRL/lpr mice

    Administration of a soluble recombinant complement C3 inhibitor protects against renal disease in MRL/lpr mice by BAD, Lihua, HAAS, Mark, KRAUS, Damian M, HACK, Bradley K, RAKSTANG, Jonathan K, HOLERS, V. Michael, QUIGG, Richard J

    “…Complement receptor 1-related gene/protein y (Crry) in rodents is a potent membrane complement regulator that inhibits complement C3 activation by both…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Structural Studies in Solution of the Recombinant N-Terminal Pair of Short Consensus/Complement Repeat Domains of Complement Receptor Type 2 (CR2/CD21) and Interactions with Its Ligand C3dg

    Structural Studies in Solution of the Recombinant N-Terminal Pair of Short Consensus/Complement Repeat Domains of Complement Receptor Type 2 (CR2/CD21) and Interactions with Its Ligand C3dg by Guthridge, Joel M, Rakstang, Jonathan K, Young, Kendra A, Hinshelwood, Justin, Aslam, Mohammed, Robertson, Alexis, Gipson, Matthew G, Sarrias, Maria-Rossa, Moore, William T, Meagher, Michael, Karp, David, Lambris, John D, Perkins, Stephen J, Holers, V. Michael

    Published in Biochemistry (Easton) (22-05-2001)
    “…Human complement receptor type 2 (CR2, CD21) is a cell surface receptor that binds three distinct ligands (complement C3d, Epstein−Barr virus gp350/220, and…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: